Side-by-side comparison of AI visibility scores, market position, and capabilities
Kooth is a publicly traded UK digital mental health company (AIM: KOO) providing NHS-commissioned mental health services for under-18s; 2025 revenues of £63.3M; serves 20M+ people in the US and UK; operates in 3 U.S.
Kooth Digital Health is a UK-based digital mental health and wellbeing company founded in 2001, incorporated as a private limited company and publicly listed on the London Stock Exchange AIM market under the ticker KOO. Kooth is the largest single-access provider of digital mental health services for children and young people under 18 in NHS England, providing free, accessible, clinically robust support with no waiting lists. The platform gives young people aged 11 to 25 access to an online community of peers, structured self-help content, and a team of experienced counsellors — available through web and mobile, with no referral required.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.